Security
newcleo plc Ordinary Shares · NWCL
NWCLNASDAQCommon stockCurrentCIK 2131813Updated Nov 5, 2026
Name history
newcleo Ltd. · through Sep 4, 2026
NWCL price & chart
Loading TradingView…
NASDAQ:NWCL on TradingView ↗About the company
new cleo is an innovative nuclear energy company developing AMRs cooled by liquid lead, and facilities to produce nuclear fuel from recycled nuclear waste, with the goal of delivering abundant, competitive, low-carbon energy. The company was founded by physicist-entrepreneur Stefano Buono following the USD $3.9 billion sale of his previous venture - Nasdaq-listed nuclear medicine company Advanced Accelerator Applications - to Novartis. With, approximately USD $780 million in private funding, and more than 900 highly skilled employees across Europe and the United States, the company has built a network of over 100 industry partnerships and supports its growth through the targeted acquisition and vertical integration of key companies in the nuclear supply chain.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Offerings
Registration 333-299328
Registration 333-297284
Filing attachments
ny20082989x1_ex107.htm · F-1 · 2026-10-06
Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) newcleo plc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Fee Rate Amount of Registration Fee(6) …
Read attachment ↗ny20082989x2_ex99-1.htm · 6-K · 2026-10-05
Exhbit 99.1 newcleo plc Reports First Half 2026 Financial and Operational Results First Half 2026 and Subsequent Commercial and Operational Highlights Completed business combination with NewHold Investment Corp III (“SPAC”) on September 21, 2026 (the “Business Combination”); newcleo’s ordinary shares and warrants commenced trading on the Nasdaq Global Select Market on September 22, 2026 under the symbols “NWCL” and “NWCLW,” respectively ──────────────────────────────────────────────────…
Read attachment ↗ny20082989x2_ex99-2.htm · 6-K · 2026-10-05
Exhibit 99.2 newcleo plc Company number: 13274878 Unaudited Condensed Consolidated Interim Financial Statements for the period ended June 30, 2026 Table of Contents CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED) 3 CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) 4 CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED) 5 CONDENSED CONS…
Read attachment ↗ny20072209x6_ex4-9.htm · F-4/A · 2026-08-03
Exhibit 4.9 WARRANT TERMINATION, ADOPTION, AMENDMENT AND NOVATION AGREEMENT THIS WARRANT TERMINATION, ADOPTION, AMENDMENT AND NOVATION AGREEMENT (this “ Agreement ”), dated as of [●], 2026, is by and among newcleo PLC, a public limited company incorporated under the laws of England and Wales (the “ Company ”), NewHold Investment Corp III, a Cayman Islands exempted company (“ NewHold ”), solely for the purposes of Section 1, Continental Stock Transfer & Trust Company, a New York corporation (“ …
Read attachment ↗ny20072209x6_ex99-1.htm · F-4/A · 2026-08-03
Exhibit 99.1 PROXY CARD NEWHOLD INVESTMENT CORP III PROXY FOR THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS The undersigned appoints Kevin Charlton and Samy Hammad, and each of them, as proxies, each with the power to appoint his substitute, and authorizes each of them to represent and to vote, as designated on the reverse hereof, all of the ordinary shares of NewHold Investment Corp III (“NewHold”) held of record by the undersigned at t…
Read attachment ↗